Abstract:OBJECTIVE:To investigate the significance of antineutrophil cytoplasmic antibody (ANCA) in hyperthyroidism at different stages and treated with different drugs and to investigate the relationship between the ANCA specific target antigens and the clinical manifestations of vasculitis.METHODS:Two hundred and sixteen patients with hyperthyroidism were divided into four groups: untreated (n = 34), treated with propylthiouracil (PTU) (n = 62), treated with methimazole (MMI) (n = 77), and treated with both PTU and MMI (n = 43). Sera were collected from the 216 patients. Indirect immunofluorescence (IIF) test was used to detect the ANCA and antinuclear antibody (ANA). Antigen-specific ELISA was used to detect the existence of 7 specific target antigens of ANCA: myeloperoxidase (MPO), proteinase 3 (PR3), lactoferrin (LF), human leukocyte elastase (HLE), azurocidin (AZU), cathepsinG (CG), and bactericidal/permeability-increasing protein (BPI) in the sera positive in ANCA and ANA determined by IIF.RESULTS:The IIF positive rate was 5.9% (2/34) in the untreated group; 22.6% (14/62) in the patients treated with PTU, all IIF-ANCA positive; 6.5% (5/77) in the patients treated with MMI, all IIF-ANA positive; and 27.9% (12/43) in the patients treated with both PTU and MMI, 8 IIF-ANA positive and 3 IIF-ANCA positive. The IIF-ANCA positive rate in the patients receiving PTU was significantly higher than that in the untreated patients (P < 0.017). The IIF-ANA and IIF-ANCA positive rates of the patients treated with PTU were both significantly higher than those of the patients treated with MMI (P < 0.017). Six of the IIF-positive 31 patients administered with drugs (19.4%) had signs and symptoms associated with vasculitis. Of the six patients, 4 were MPO antibody positive (66.7%), 2 were PR3 antibody positive (33.3%), 4 were LF antibody positive, 3 were HLE antibody positive, 3 were AZU antibody positive, and 2 were CG antibody positive. None was anti-BPI antibody positive. Two of the six patients were both anti-MPO and anti-PR3 negative. All MPO-ANCA positive patients had clinical signs and symptoms of vasculitis.CONCLUSION:PTU is associated with the production of ANCA in patients with hyperthyroidism. PTU induced ANCA is caused by polyclonal activation of B cells. Anti-MPO antibody may be related to the occurrence of clinical vasculitis.

Research Progress in Antineutrophil Cytoplasmtic Antibody Associated Small Vessel Vasculitis Due to Propylthiouracil

Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis with Renal and Lung Involvement

Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis

[Antineutrophil Cytoplasmic Autoantibody Positive Vasculitis Induced by Propylthiouracil: a Case Report].

Clinico-pathological features and outcomes of patients with propylthiouracil-associated ANCA vasculitis with renal involvement

Propylthiouracil-Induced Vasculitis With Alveolar Hemorrhage Confirmed by Clinical, Laboratory, Computed Tomography, and Bronchoscopy Findings: A Case Report and Literature Review

[Clinicopathological Characteristics of Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibodies-Positive Vasculitis and Their Target Antigens: a Report of 4 Cases and Literature Review].

Case report: Propylthiouracil-induced serious side effect: Perinuclear antineutrophil cytoplasmic antibody-associated vasculitis or IgA vasculitis?

Pathogenesis and treatment progress of antineutrophil cytoplasmic antibody-associated vasculitis

The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil.

[Antineutrophil Cytoplasmic Antibody Associated Vasculitis Induced by Antithyroid Agents].

Clinic-pathological features and otcomes of patients with propylthiouracil-associated ANCA vasculitis

Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Overlap IgA Nephropathy: A Case Report

Clinical Characteristics and Outcomes of Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Patients with Graves' Disease: A Median 38-Month Retrospective Cohort Study from a Single Institution in China.

Clinical and Pathological Features of Renal Involvement in Propylthiouracil-Associated Anca-Positive Vasculitis

Clinical characteristics of nineteen vasculitis patients associated with propylthiouracil-induced antineutrophil cytoplasmic antibody

Study on propylthiouracil,methimazole and antineutropil cytoplasmic antibody-associated vasculitis

[Clinical Features and Outcomes of Hyperthyroidism Patients Positive in Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody].

Propylthiouracil Induced Pulmonary Vasculitis in 1 Patient

Follow‐up of Avidity and Titre of Anti‐myeloperoxidase Antibodies in Sera from Patients with Propylthiouracil‐induced Vasculitis

Vasculitis Associated with Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody is Not Drug Induced Lupus